HPV vaccine 2-valent, 2 doses

General Description:
Human Papillomavirus vaccine, bivalent, types 16 and 18, recombinant virus like particle vaccine, 2 dose vial with VVM30.

Human Papillomavirus vaccine is indicated for use in females aged 9 to 26 years for the prevention of cervical, vulvar, and vaginal cancer, precancerous or dysplastic lesions, genital warts, and persistent infection caused by Human Papillomavirus Types, 16 and 18 (which are included in the vaccine).

The use of Human Papillomavirus vaccine should be based on official recommendations.

Immunization schedule:
Human Papillomavirus vaccine should be administered intramuscularly as 3 separate 0.5-ml doses according to the following schedule:

First dose: at elected time
Second dose: 1 month after the first dose
Third dose: 6 months after the first dose

Packaging, transport and storage:
Human Papillomavirus vaccine must be stored and transported between +2°C and +8°C.
Human Papillomavirus vaccine MUST NOT BE FROZEN.
The vaccine should be protected from light.

Available in cartons of ten 0.5-ml single-dose vials, with VVM30. Cold chain volume per dose: 4.8 cm3 per dose (carton of 100 vials), 5.7cm3 per dose (carton of 10 vials), 28.8cm3 per dose (carton of 1 vial)


For information on product specifications, please see the WHO website on Prequalified Vaccines at
https://www.who.int/immunization_standards/vacc ine_quality/PQ_181_HPV_GSK_2_dose/en/

For more information on WHO’s recommendation for use of Human Papillomavirus vaccine, please see
https://www.who.int/immun ization/en/

Estimated Volume:
Estimated volume:
4.8 cm3(carton of 100vials) per dose
5.7 cm3 (carton of 10 vials) per dose
28.8 cm3 (carton of 1 vial) per dose